121 related articles for article (PubMed ID: 38272394)
1. Baseline Serum neutrophil-to-lymphocyte ratio in acral melanoma compared with nonacral melanoma and its prognostic significance.
Choi ME; Jung JM; Kim DH; Won CH; Chang SE; Lee MW; Lee WJ
J Am Acad Dermatol; 2024 May; 90(5):977-985. PubMed ID: 38272394
[TBL] [Abstract][Full Text] [Related]
2. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
3. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
Loya A; Gombos DS; Patel SP
Front Oncol; 2022; 12():853076. PubMed ID: 35372013
[TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
[TBL] [Abstract][Full Text] [Related]
6. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
7. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
8. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of acral melanoma: a series of 281 patients.
Bello DM; Chou JF; Panageas KS; Brady MS; Coit DG; Carvajal RD; Ariyan CE
Ann Surg Oncol; 2013 Oct; 20(11):3618-25. PubMed ID: 23838913
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
Cheraghlou S; Ugwu N; Girardi M
JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
[TBL] [Abstract][Full Text] [Related]
11. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
[TBL] [Abstract][Full Text] [Related]
12. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
[TBL] [Abstract][Full Text] [Related]
13. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
[TBL] [Abstract][Full Text] [Related]
14. Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis.
Häfliger EM; Ramelyte E; Mangana J; Kunz M; Kazakov DV; Dummer R; Cheng PF
Melanoma Res; 2018 Oct; 28(5):442-450. PubMed ID: 29847461
[TBL] [Abstract][Full Text] [Related]
15. Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma.
Susok L; Gambichler T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):497-502. PubMed ID: 33856527
[TBL] [Abstract][Full Text] [Related]
16. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
Kuchelmeister C; Schaumburg-Lever G; Garbe C
Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
[TBL] [Abstract][Full Text] [Related]
17. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
[TBL] [Abstract][Full Text] [Related]
19. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
Bradford PT; Goldstein AM; McMaster ML; Tucker MA
Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]